Literature DB >> 24203977

Different mutations in PDE4D associated with developmental disorders with mirror phenotypes.

Anna Lindstrand1, Giedre Grigelioniene, Daniel Nilsson, Maria Pettersson, Wolfgang Hofmeister, Britt-Marie Anderlid, Sarina G Kant, Claudia A L Ruivenkamp, Peter Gustavsson, Helena Valta, Stefan Geiberger, Alexandra Topa, Kristina Lagerstedt-Robinson, Fulya Taylan, Josephine Wincent, Tobias Laurell, Minna Pekkinen, Magnus Nordenskjöld, Outi Mäkitie, Ann Nordgren.   

Abstract

BACKGROUND: Point mutations in PDE4D have been recently linked to acrodysostosis, an autosomal dominant disorder with skeletal dysplasia, severe brachydactyly, midfacial hypoplasia and intellectual disability. The purpose of the present study was to investigate clinical and cellular implications of different types of mutations in the PDE4D gene.
METHODS: We studied five acrodysostosis patients and three patients with gene dose imbalances involving PDE4D clinically and by whole exome sequencing, Sanger sequencing and array comparative hybridisation. To evaluate the functional consequences of the PDE4D changes, we used overexpression of mutated human PDE4D message and morpholino-based suppression of pde4d in zebrafish.
RESULTS: We identified three novel and two previously described PDE4D point mutations in the acrodysostosis patients and two deletions and one duplication involving PDE4D in three patients suffering from an intellectual disability syndrome with low body mass index, long fingers, toes and arms, prominent nose and small chin. When comparing symptoms in patients with missense mutations and gene dose imbalances involving PDE4D, a mirror phenotype was observed. By comparing overexpression of human mutated transcripts with pde4d knockdown in zebrafish embryos, we could successfully assay the pathogenicity of the mutations.
CONCLUSIONS: Our findings indicate that haploinsufficiency of PDE4D results in a novel intellectual disability syndrome, the 5q12.1-haploinsufficiency syndrome, with several opposing features compared with acrodysostosis that is caused by dominant negative mutations. In addition, our results expand the spectrum of PDE4D mutations underlying acrodysostosis and indicate that, in contrast to previous reports, patients with PDE4D mutations may have significant hormone resistance with consequent endocrine abnormalities.

Entities:  

Keywords:  Clinical Genetics; Copy-Number; Developmental; Other Endocrinology; Other Neurology

Mesh:

Substances:

Year:  2013        PMID: 24203977     DOI: 10.1136/jmedgenet-2013-101937

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  27 in total

1.  Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutations.

Authors:  Ola Nilsson; Michael H Guo; Nancy Dunbar; Jadranka Popovic; Daniel Flynn; Christina Jacobsen; Julian C Lui; Joel N Hirschhorn; Jeffrey Baron; Andrew Dauber
Journal:  J Clin Endocrinol Metab       Date:  2014-04-24       Impact factor: 5.958

Review 2.  Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.

Authors:  Giovanna Mantovani; Anna Spada; Francesca Marta Elli
Journal:  Nat Rev Endocrinol       Date:  2016-04-22       Impact factor: 43.330

Review 3.  Genetics of Short Stature.

Authors:  Youn Hee Jee; Anenisia C Andrade; Jeffrey Baron; Ola Nilsson
Journal:  Endocrinol Metab Clin North Am       Date:  2017-02-23       Impact factor: 4.741

4.  Engineered stabilization and structural analysis of the autoinhibited conformation of PDE4.

Authors:  Peder Cedervall; Ann Aulabaugh; Kieran F Geoghegan; Thomas J McLellan; Jayvardhan Pandit
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-09       Impact factor: 11.205

5.  A Heterozygous Splice-Site Mutation in PTHLH Causes Autosomal Dominant Shortening of Metacarpals and Metatarsals.

Authors:  Monica Reyes; Bert Bravenboer; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2019-01-02       Impact factor: 6.741

6.  RACK1 and β-arrestin2 attenuate dimerization of PDE4 cAMP phosphodiesterase PDE4D5.

Authors:  Graeme B Bolger
Journal:  Cell Signal       Date:  2015-08-06       Impact factor: 4.315

7.  Expanding the phenotypic spectrum of variants in PDE4D/PRKAR1A: from acrodysostosis to acroscyphodysplasia.

Authors:  Caroline Michot; Carine Le Goff; Edward Blair; Patricia Blanchet; Yline Capri; Brigitte Gilbert-Dussardier; Alice Goldenberg; Alex Henderson; Bertrand Isidor; Hulya Kayserili; Esther Kinning; Martine Le Merrer; Stanislas Lyonnet; Sylvie Odent; Pelin Ozlem Simsek-Kiper; Chloé Quelin; Ravi Savarirayan; Marleen Simon; Miranda Splitt; Judith M A Verhagen; Alain Verloes; Arnold Munnich; Geneviève Baujat; Valérie Cormier-Daire
Journal:  Eur J Hum Genet       Date:  2018-07-13       Impact factor: 4.246

8.  Shortened Fingers and Toes: GNAS Abnormalities are Not the Only Cause.

Authors:  Monica Reyes; Caroline Silve; Harald Jüppner
Journal:  Exp Clin Endocrinol Diabetes       Date:  2019-12-11       Impact factor: 2.949

9.  Variants in regulatory elements of PDE4D associate with major mental illness in the Finnish population.

Authors:  Vishal Sinha; Liisa Ukkola-Vuoti; Alfredo Ortega-Alonso; Minna Torniainen-Holm; Sebastian Therman; Annamari Tuulio-Henriksson; Pekka Jylhä; Jaakko Kaprio; Iiris Hovatta; Erkki Isometsä; Tyrone D Cannon; Jouko Lönnqvist; Tiina Paunio; Jaana Suvisaari; William Hennah
Journal:  Mol Psychiatry       Date:  2019-05-28       Impact factor: 15.992

10.  A negative allosteric modulator of PDE4D enhances learning after traumatic brain injury.

Authors:  David J Titus; Nicole M Wilson; Oscar Alcazar; Dale A Calixte; W Dalton Dietrich; Mark E Gurney; Coleen M Atkins
Journal:  Neurobiol Learn Mem       Date:  2017-12-30       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.